FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3164823163> ?p ?o ?g. }

• W3164823163 endingPage "871" @default.
• W3164823163 startingPage "862" @default.
• W3164823163 abstract "ObjectiveTo assess the risk of type 2 diabetes (T2D) in women with polycystic ovary syndrome (PCOS) in relation to body mass index (BMI) and the hyperandrogenic (HA) PCOS phenotype.DesignPopulation-based cohort study.SettingData from six Swedish national registers, with participants being followed for a maximum of 19 years.Patient(s)All women with an International Statistical Classification of Diseases and Related Health Problems, version 10, diagnosis of PCOS, androgen excess, or anovulatory infertility born between 1950 and 1999 (n = 52,535) were identified in the Patient Register. The HA PCOS phenotype was defined by two filled prescriptions for anti-androgenic drugs. For each woman with PCOS, five control women (n = 254,624) were randomly chosen from the Total Population Register, matched for age and geographic area.Intervention(s)No interventions were performed.Main Outcome Measure(s)International Statistical Classification of Diseases and Related Health Problems, version 10, diagnosis of T2D or prescription of antidiabetic treatment other than metformin.Result(s)The cumulative incidence rates of T2D were 1.3%, 4.4%, and 14.2% in controls (non-PCOS women) and women with normoandrogenic (NA) and HA PCOS, respectively. After adjustment for BMI, women with PCOS had a twofold higher rate of T2D than non-PCOS women (adjusted hazard ratio, 2.52 [95% confidence interval, 2.15–2.96]). Women with HA PCOS had a higher rate of T2D than those with NA PCOS (adjusted hazard ratio, 3.86 [95% confidence interval, 3.16–4.72]).Conclusion(s)Polycystic ovary syndrome is an independent risk factor for T2D, even after adjustment for BMI. Women with the HA PCOS phenotype face an even higher risk of T2D than those with the NA PCOS phenotype. To assess the risk of type 2 diabetes (T2D) in women with polycystic ovary syndrome (PCOS) in relation to body mass index (BMI) and the hyperandrogenic (HA) PCOS phenotype. Population-based cohort study. Data from six Swedish national registers, with participants being followed for a maximum of 19 years. All women with an International Statistical Classification of Diseases and Related Health Problems, version 10, diagnosis of PCOS, androgen excess, or anovulatory infertility born between 1950 and 1999 (n = 52,535) were identified in the Patient Register. The HA PCOS phenotype was defined by two filled prescriptions for anti-androgenic drugs. For each woman with PCOS, five control women (n = 254,624) were randomly chosen from the Total Population Register, matched for age and geographic area. No interventions were performed. International Statistical Classification of Diseases and Related Health Problems, version 10, diagnosis of T2D or prescription of antidiabetic treatment other than metformin. The cumulative incidence rates of T2D were 1.3%, 4.4%, and 14.2% in controls (non-PCOS women) and women with normoandrogenic (NA) and HA PCOS, respectively. After adjustment for BMI, women with PCOS had a twofold higher rate of T2D than non-PCOS women (adjusted hazard ratio, 2.52 [95% confidence interval, 2.15–2.96]). Women with HA PCOS had a higher rate of T2D than those with NA PCOS (adjusted hazard ratio, 3.86 [95% confidence interval, 3.16–4.72]). Polycystic ovary syndrome is an independent risk factor for T2D, even after adjustment for BMI. Women with the HA PCOS phenotype face an even higher risk of T2D than those with the NA PCOS phenotype." @default.
• W3164823163 created "2021-06-07" @default.
• W3164823163 creator A5000415093 @default.
• W3164823163 creator A5045875410 @default.
• W3164823163 creator A5050091833 @default.
• W3164823163 creator A5055188534 @default.
• W3164823163 creator A5069419499 @default.
• W3164823163 creator A5082067962 @default.
• W3164823163 date "2021-09-01" @default.
• W3164823163 modified "2023-10-14" @default.
• W3164823163 title "Higher risk of type 2 diabetes in women with hyperandrogenic polycystic ovary syndrome" @default.
• W3164823163 cites W1973928540 @default.
• W3164823163 cites W1984067141 @default.
• W3164823163 cites W2018040934 @default.
• W3164823163 cites W2035263233 @default.
• W3164823163 cites W2036541663 @default.
• W3164823163 cites W2053369310 @default.
• W3164823163 cites W2058294720 @default.
• W3164823163 cites W2101316067 @default.
• W3164823163 cites W2110503690 @default.
• W3164823163 cites W2114250987 @default.
• W3164823163 cites W2120558931 @default.
• W3164823163 cites W2120973019 @default.
• W3164823163 cites W2133421321 @default.
• W3164823163 cites W2141761576 @default.
• W3164823163 cites W2166018731 @default.
• W3164823163 cites W2170563191 @default.
• W3164823163 cites W2186218348 @default.
• W3164823163 cites W2233885014 @default.
• W3164823163 cites W2344079925 @default.
• W3164823163 cites W2345328813 @default.
• W3164823163 cites W2347160720 @default.
• W3164823163 cites W2398526138 @default.
• W3164823163 cites W2481420451 @default.
• W3164823163 cites W2523733243 @default.
• W3164823163 cites W2528179062 @default.
• W3164823163 cites W2564015027 @default.
• W3164823163 cites W2618971303 @default.
• W3164823163 cites W2751209738 @default.
• W3164823163 cites W2762547081 @default.
• W3164823163 cites W2789960609 @default.
• W3164823163 cites W2897714751 @default.
• W3164823163 cites W2900701301 @default.
• W3164823163 cites W2903030121 @default.
• W3164823163 cites W2911538911 @default.
• W3164823163 cites W2949454448 @default.
• W3164823163 cites W2957117910 @default.
• W3164823163 cites W2965877220 @default.
• W3164823163 cites W4251646064 @default.
• W3164823163 doi "https://doi.org/10.1016/j.fertnstert.2021.04.018" @default.
• W3164823163 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34053678" @default.
• W3164823163 hasPublicationYear "2021" @default.
• W3164823163 type Work @default.
• W3164823163 sameAs 3164823163 @default.
• W3164823163 citedByCount "14" @default.
• W3164823163 countsByYear W31648231632021 @default.
• W3164823163 countsByYear W31648231632022 @default.
• W3164823163 countsByYear W31648231632023 @default.
• W3164823163 crossrefType "journal-article" @default.
• W3164823163 hasAuthorship W3164823163A5000415093 @default.
• W3164823163 hasAuthorship W3164823163A5045875410 @default.
• W3164823163 hasAuthorship W3164823163A5050091833 @default.
• W3164823163 hasAuthorship W3164823163A5055188534 @default.
• W3164823163 hasAuthorship W3164823163A5069419499 @default.
• W3164823163 hasAuthorship W3164823163A5082067962 @default.
• W3164823163 hasBestOaLocation W31648231631 @default.
• W3164823163 hasConcept C126322002 @default.
• W3164823163 hasConcept C131872663 @default.
• W3164823163 hasConcept C134018914 @default.
• W3164823163 hasConcept C156957248 @default.
• W3164823163 hasConcept C207103383 @default.
• W3164823163 hasConcept C2777180221 @default.
• W3164823163 hasConcept C2777391703 @default.
• W3164823163 hasConcept C2777688143 @default.
• W3164823163 hasConcept C2779234561 @default.
• W3164823163 hasConcept C2780186808 @default.
• W3164823163 hasConcept C2780221984 @default.
• W3164823163 hasConcept C2780323712 @default.
• W3164823163 hasConcept C2780853582 @default.
• W3164823163 hasConcept C2908647359 @default.
• W3164823163 hasConcept C29456083 @default.
• W3164823163 hasConcept C3018442814 @default.
• W3164823163 hasConcept C44249647 @default.
• W3164823163 hasConcept C54355233 @default.
• W3164823163 hasConcept C555293320 @default.
• W3164823163 hasConcept C71924100 @default.
• W3164823163 hasConcept C86803240 @default.
• W3164823163 hasConcept C99454951 @default.
• W3164823163 hasConceptScore W3164823163C126322002 @default.
• W3164823163 hasConceptScore W3164823163C131872663 @default.
• W3164823163 hasConceptScore W3164823163C134018914 @default.
• W3164823163 hasConceptScore W3164823163C156957248 @default.
• W3164823163 hasConceptScore W3164823163C207103383 @default.
• W3164823163 hasConceptScore W3164823163C2777180221 @default.
• W3164823163 hasConceptScore W3164823163C2777391703 @default.
• W3164823163 hasConceptScore W3164823163C2777688143 @default.
• W3164823163 hasConceptScore W3164823163C2779234561 @default.
• W3164823163 hasConceptScore W3164823163C2780186808 @default.

• next